EVIDENCE FOR A BONE-MARROW B-CELL TRANSCRIBING MALIGNANT PLASMA-CELL VDJ JOINED TO C-MU SEQUENCE IN IMMUNOGLOBULIN (IGG)-SECRETING AND IGA-SECRETING MULTIPLE MYELOMAS
P. Corradini et al., EVIDENCE FOR A BONE-MARROW B-CELL TRANSCRIBING MALIGNANT PLASMA-CELL VDJ JOINED TO C-MU SEQUENCE IN IMMUNOGLOBULIN (IGG)-SECRETING AND IGA-SECRETING MULTIPLE MYELOMAS, The Journal of experimental medicine, 178(3), 1993, pp. 1091-1096
Multiple myeloma is a B cell malignancy characterized by the expansion
of plasma cells producing monoclonal immunoglobulins (Ig). It has bee
n regarded as a tumor arising at the B, pre-B lymphocyte, or even stem
cell level. Precursor cells are presumed to proliferate and different
iate giving rise to the plasma cell clonal expansion. Antigenic featur
es and specific Ig gene rearrangement shared by B lymphocytes and myel
oma cells have supported this hypothesis. However, the existence of su
ch a precursor is based upon indirect evidence and is still an open qu
estion. During differentiation, B cells rearrange variable (V) regions
of Ig heavy chain genes, providing a specific marker of clonality. Us
ing an anchor polymerase chain reaction assay, these rearranged region
s from five patients with multiple myeloma were cloned and sequenced.
The switch of the Ig constant (C) region was used to define the B cell
differentiation stage: V regions are linked to Cmu genes in pre-B and
B lymphocytes (pre-switch B cells), but to Cgamma or Calpha in post-s
witch B lymphocytes and plasma cells (post-switch B cells). Analysis o
f bone marrow cells at diagnosis revealed the presence of pre-switch B
cells bearing plasma cell V regions still joined to the Cmu gene. The
se cells were not identified in peripheral blood, where tumor post-swi
tch B cells were detected. These pre-switch B cells may be regarded as
potential myeloma cell precursors.